Cost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and Zimbabwe.
Nyanzi Wakaholi, B
DART Trial Team
Public Library of Science
Despite funding constraints for treatment programmes in Africa, the costs and economic consequences of routine laboratory monitoring for efficacy and toxicity of antiretroviral therapy (ART) have rarely been evaluated.
addresses: Health Economics Group, Peninsula College of Medicine and Dentistry, Exeter University, Exeter, United Kingdom.
notes: PMCID: PMC3335836
types: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Copyright: © 2012 Medina Lara et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
PLoS One, 2012, Vol. 7, Issue 4, pp. e33672 -
Place of publication